These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2258326)

  • 1. Epimerization of erythromycin derivatives.
    Firl J; Prox A; Luger P; Maier R; Woitun E; Daneck K
    J Antibiot (Tokyo); 1990 Oct; 43(10):1271-7. PubMed ID: 2258326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial characterization and interrelationships of dirithromycin and epidirithromycin.
    Kirst HA; Creemer LC; Paschal JW; Preston DA; Alborn WE; Counter FT; Amos JG; Clemens RL; Sullivan KA; Greene JM
    Antimicrob Agents Chemother; 1995 Jul; 39(7):1436-41. PubMed ID: 7492081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A computational approach to the synthesis of dirithromycin.
    Duran D; Aviyente V; Baysal C
    J Mol Model; 2004 Apr; 10(2):94-101. PubMed ID: 14722740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dirithromycin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy.
    Brogden RN; Peters DH
    Drugs; 1994 Oct; 48(4):599-616. PubMed ID: 7528132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural elucidation of a novel erythromycin, 13-cyclopentyl-13-desethyl-erythromycin B, from a recombinant Saccharopolyspora erythraea strain, NRRL 2338 pIG/1.
    Parsons IC; Everett JR; Pacey MS; Ruddock JC; Swanson AG; Thompson CM
    J Antibiot (Tokyo); 1999 Feb; 52(2):190-2. PubMed ID: 10344576
    [No Abstract]   [Full Text] [Related]  

  • 6. Quantitative analysis of erythromycylamine in human plasma by liquid chromatography-tandem mass spectrometry and its application in a bioequivalence study of dirithromycin enteric-coated tablets with a special focus on the fragmentation pattern and carryover effect.
    Cai HL; Wang F; Li HD; Peng WX; Zhu RH; Deng Y; Jiang P; Yan M; Hu SM; Lei SY; Chen C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Feb; 947-948():156-63. PubMed ID: 24424301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical efficacy of dirithromycin in pneumonia.
    Jacobson K
    J Antimicrob Chemother; 1993 Mar; 31 Suppl C():121-9. PubMed ID: 8478303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical efficacy of dirithromycin in acute exacerbations of chronic bronchitis.
    Sides GD
    J Antimicrob Chemother; 1993 Mar; 31 Suppl C():131-8. PubMed ID: 8478304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dirithromycin in the treatment of skin and skin structure infections.
    Derriennic M; Escande JP
    J Antimicrob Chemother; 1993 Mar; 31 Suppl C():159-68. PubMed ID: 8478307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative efficacy of 5 days of dirithromycin and 7 days of erythromycin in skin and soft tissue infections.
    Wasilewski MM; Wilson MG; Sides GD; Stotka JL
    J Antimicrob Chemother; 2000 Aug; 46(2):255-62. PubMed ID: 10933649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dirithromycin: a new macrolide.
    Wintermeyer SM; Abdel-Rahman SM; Nahata MC
    Ann Pharmacother; 1996 Oct; 30(10):1141-9. PubMed ID: 8893122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analytical-physical profile of the novel macrolide antibiotic flurithromycin ethylsuccinate.
    Colombo N; Depaoli A; Gobetti M; Saorin MG
    Arzneimittelforschung; 1994 Jul; 44(7):850-5. PubMed ID: 7945521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multicentre study comparing the safety and efficacy of dirithromycin with erythromycin in the treatment of bronchitis.
    Gaillat J
    J Antimicrob Chemother; 1993 Mar; 31 Suppl C():139-51. PubMed ID: 8478305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dirithromycin in the treatment of streptococcal pharyngitis.
    Derriennic M; Conforti PM; Sides GD
    J Antimicrob Chemother; 1993 Mar; 31 Suppl C():89-95. PubMed ID: 8478315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-vitro activity of dirithromycin against Chlamydia pneumoniae.
    Roblin PM; Kutlin A; Sokolovskaya N; Hammerschlag MR
    J Antimicrob Chemother; 1997 May; 39(5):647-9. PubMed ID: 9184366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical efficacy of dirithromycin in pharyngitis and tonsillitis.
    Müller O; Wettich K
    J Antimicrob Chemother; 1993 Mar; 31 Suppl C():97-102. PubMed ID: 8478316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Five-day dirithromycin therapy is as effective as seven-day erythromycin therapy for acute exacerbations of chronic bronchitis.
    Wasilewski MM; Johns D; Sides GD
    J Antimicrob Chemother; 1999 Apr; 43(4):541-8. PubMed ID: 10350384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solid-state investigations of erythromycin A dihydrate: structure, NMR spectroscopy, and hygroscopicity.
    Stephenson GA; Stowell JG; Toma PH; Pfeiffer RR; Byrn SR
    J Pharm Sci; 1997 Nov; 86(11):1239-44. PubMed ID: 9383733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of the in-vitro uptake, intraphagocytic biological activity and effects on neutrophil superoxide generation of dirithromycin compared with erythromycin.
    Jooné GK; Van Rensburg CE; Anderson R
    J Antimicrob Chemother; 1992 Oct; 30(4):509-23. PubMed ID: 1337069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dirithromycin disc susceptibility tests: interpretative criteria and quality control parameters.
    Barry AL; Pfaller MA; Fuchs PC
    J Antimicrob Chemother; 1993 Mar; 31 Suppl C():27-37. PubMed ID: 8478310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.